Annual CFF
$17.75 M
+$11.25 M+173.28%
December 31, 2023
Summary
- As of February 8, 2025, PMN annual cash flow from financing activities is $17.75 million, with the most recent change of +$11.25 million (+173.28%) on December 31, 2023.
- During the last 3 years, PMN annual CFF has risen by +$14.74 million (+490.33%).
- PMN annual CFF is now -30.46% below its all-time high of $25.52 million, reached on December 31, 2021.
Performance
PMN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$27.22 M
+$27.22 M+100.00%
September 30, 2024
Summary
- As of February 8, 2025, PMN quarterly cash flow from financing activities is $27.22 million, with the most recent change of +$27.22 million (+100.00%) on September 30, 2024.
- Over the past year, PMN quarterly CFF has increased by +$8.96 million (+49.05%).
- PMN quarterly CFF is now at all-time high.
Performance
PMN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$26.90 M
+$8.96 M+49.93%
September 30, 2024
Summary
- As of February 8, 2025, PMN TTM cash flow from financing activities is $26.90 million, with the most recent change of +$8.96 million (+49.93%) on September 30, 2024.
- Over the past year, PMN TTM CFF has increased by +$2.14 million (+8.65%).
- PMN TTM CFF is now at all-time high.
Performance
PMN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PMN Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +173.3% | +49.0% | +8.7% |
3 y3 years | +490.3% | +100.0% | +10000.0% |
5 y5 years | +158.7% | +293.2% | +190.7% |
PMN Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -30.5% | +173.3% | at high | +5430.1% | at high | >+9999.0% |
5 y | 5-year | -30.5% | +490.3% | at high | +5430.1% | at high | >+9999.0% |
alltime | all time | -30.5% | +8120.8% | at high | +5430.1% | at high | -100.0% |
ProMIS Neurosciences Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $27.22 M(>+9900.0%) | $26.90 M(+49.9%) |
Jun 2024 | - | $0.00(-100.0%) | $17.94 M(0.0%) |
Mar 2024 | - | $190.30 K(-137.3%) | $17.94 M(+1.1%) |
Dec 2023 | $17.75 M(+173.3%) | -$510.60 K(-102.8%) | $17.75 M(-28.3%) |
Sep 2023 | - | $18.26 M(>+9900.0%) | $24.75 M(+281.1%) |
Jun 2023 | - | $0.00(0.0%) | $6.49 M(0.0%) |
Mar 2023 | - | $0.00(-100.0%) | $6.49 M(0.0%) |
Dec 2022 | $6.49 M(-74.6%) | $6.49 M(>+9900.0%) | $6.49 M(>+9900.0%) |
Sep 2022 | - | $0.00(-100.0%) | $400.00(-100.0%) |
Dec 2021 | $25.52 M(+748.9%) | $400.00(-100.0%) | $25.52 M(-5.1%) |
Sep 2021 | - | $18.64 M(<-9900.0%) | $26.89 M(+224.7%) |
Jun 2021 | - | -$39.10 K(-100.6%) | $8.28 M(-10.5%) |
Mar 2021 | - | $6.92 M(+407.0%) | $9.25 M(+207.8%) |
Dec 2020 | $3.01 M(-26.8%) | $1.37 M(+4074.6%) | $3.01 M(-19.7%) |
Sep 2020 | - | $32.70 K(-96.5%) | $3.74 M(+1.3%) |
Jun 2020 | - | $933.20 K(+38.1%) | $3.69 M(+2.2%) |
Mar 2020 | - | $675.50 K(-67.9%) | $3.61 M(-12.0%) |
Dec 2019 | $4.10 M(-40.2%) | - | - |
Dec 2019 | - | $2.10 M(<-9900.0%) | $4.10 M(+93.9%) |
Sep 2019 | - | -$16.80 K(-102.0%) | $2.12 M(-12.2%) |
Jun 2019 | - | $852.80 K(-26.9%) | $2.41 M(-64.7%) |
Mar 2019 | - | $1.17 M(+915.2%) | $6.83 M(-0.5%) |
Dec 2018 | $6.86 M(+29.2%) | - | - |
Dec 2018 | - | $114.90 K(-58.4%) | $6.86 M(+3.1%) |
Sep 2018 | - | $276.20 K(-94.8%) | $6.66 M(-31.8%) |
Jun 2018 | - | $5.27 M(+339.5%) | $9.76 M(+114.4%) |
Mar 2018 | - | $1.20 M(-1456.6%) | $4.55 M(-14.2%) |
Dec 2017 | $5.31 M(+203.3%) | -$88.40 K(-102.6%) | $5.31 M(-0.8%) |
Sep 2017 | - | $3.38 M(+5435.0%) | $5.35 M(+75.7%) |
Jun 2017 | - | $61.10 K(-96.9%) | $3.05 M(-5.9%) |
Mar 2017 | - | $1.96 M(-4425.9%) | $3.24 M(+84.9%) |
Dec 2016 | $1.75 M(-2.5%) | -$45.20 K(-104.2%) | $1.75 M(+0.9%) |
Sep 2016 | - | $1.07 M(+328.2%) | $1.74 M(-28.1%) |
Jun 2016 | - | $251.00 K(-46.6%) | $2.41 M(+8.1%) |
Mar 2016 | - | $470.00 K(-876.9%) | $2.23 M(+24.3%) |
Dec 2015 | $1.80 M | -$60.50 K(-103.5%) | $1.80 M(-3.3%) |
Sep 2015 | - | $1.75 M(+2366.8%) | $1.86 M(+2667.1%) |
Jun 2015 | - | $71.00 K(+107.0%) | $67.10 K(-92.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2015 | - | $34.30 K(-189.8%) | $860.90 K(-52.3%) |
Dec 2014 | $1.08 M(-36.9%) | - | - |
Sep 2014 | - | -$38.20 K(-104.4%) | $1.81 M(-2.8%) |
Jun 2014 | - | $864.80 K(+1.4%) | $1.86 M(+8.1%) |
Mar 2014 | $1.72 M(+54.1%) | $852.90 K(+578.5%) | $1.72 M(+68.6%) |
Dec 2013 | - | $125.70 K(+766.9%) | $1.02 M(+15.4%) |
Sep 2013 | - | $14.50 K(-98.0%) | $883.20 K(-1.9%) |
Jun 2013 | - | $725.20 K(+371.5%) | $900.10 K(-19.3%) |
Mar 2013 | $1.11 M(+69.3%) | $153.80 K(-1593.2%) | $1.12 M(-31.2%) |
Dec 2012 | - | -$10.30 K(-132.8%) | $1.62 M(-0.6%) |
Sep 2012 | - | $31.40 K(-96.7%) | $1.63 M(+2.0%) |
Jun 2012 | - | $940.20 K(+42.8%) | $1.60 M(+142.8%) |
Mar 2012 | $658.60 K(+35.5%) | $658.60 K(>+9900.0%) | $658.60 K(+35.5%) |
Dec 2011 | - | $0.00(0.0%) | $485.90 K(0.0%) |
Sep 2011 | - | $0.00(0.0%) | $485.90 K(0.0%) |
Jun 2011 | - | $0.00(-100.0%) | $485.90 K(0.0%) |
Mar 2011 | $485.90 K(-86.7%) | $485.90 K(>+9900.0%) | $485.90 K(+390.3%) |
Dec 2010 | - | $0.00(-100.0%) | $99.10 K(-97.3%) |
Mar 2010 | $3.65 M(+1590.1%) | $99.10 K(-74.9%) | $3.65 M(+3.0%) |
Dec 2009 | - | $394.60 K(-21.4%) | $3.54 M(+5.1%) |
Sep 2009 | - | $501.90 K(-81.1%) | $3.37 M(+17.5%) |
Jun 2009 | - | $2.65 M(<-9900.0%) | $2.87 M(+1229.0%) |
Mar 2009 | $215.90 K(-73.7%) | -$8100.00(-103.6%) | $215.90 K(-8.9%) |
Dec 2008 | - | $224.00 K(>+9900.0%) | $237.10 K(+109.3%) |
Sep 2008 | - | $0.00(0.0%) | $113.30 K(-76.9%) |
Jun 2008 | - | $0.00(-100.0%) | $490.50 K(-40.2%) |
Mar 2008 | $820.80 K(-92.2%) | $13.10 K(-86.9%) | $820.70 K(-90.8%) |
Dec 2007 | - | $100.20 K(-73.4%) | $8.93 M(-6.9%) |
Sep 2007 | - | $377.20 K(+14.2%) | $9.58 M(-7.0%) |
Jun 2007 | - | $330.20 K(-95.9%) | $10.30 M(-2.2%) |
Mar 2007 | $10.53 M(+90.1%) | $8.12 M(+972.9%) | $10.53 M(+95.6%) |
Dec 2006 | - | $756.60 K(-30.8%) | $5.38 M(+15.6%) |
Sep 2006 | - | $1.09 M(+95.9%) | $4.66 M(-23.6%) |
Jun 2006 | - | $558.20 K(-81.2%) | $6.10 M(+10.1%) |
Mar 2006 | $5.54 M | $2.97 M(+9712.2%) | $5.54 M(+116.0%) |
Dec 2005 | - | $30.30 K(-98.8%) | $2.56 M(+1.2%) |
Sep 2005 | - | $2.53 M(>+9900.0%) | $2.53 M(>+9900.0%) |
Jun 2005 | - | $0.00 | $0.00 |
FAQ
- What is ProMIS Neurosciences annual cash flow from financing activities?
- What is the all time high annual CFF for ProMIS Neurosciences?
- What is ProMIS Neurosciences annual CFF year-on-year change?
- What is ProMIS Neurosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for ProMIS Neurosciences?
- What is ProMIS Neurosciences quarterly CFF year-on-year change?
- What is ProMIS Neurosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for ProMIS Neurosciences?
- What is ProMIS Neurosciences TTM CFF year-on-year change?
What is ProMIS Neurosciences annual cash flow from financing activities?
The current annual CFF of PMN is $17.75 M
What is the all time high annual CFF for ProMIS Neurosciences?
ProMIS Neurosciences all-time high annual cash flow from financing activities is $25.52 M
What is ProMIS Neurosciences annual CFF year-on-year change?
Over the past year, PMN annual cash flow from financing activities has changed by +$11.25 M (+173.28%)
What is ProMIS Neurosciences quarterly cash flow from financing activities?
The current quarterly CFF of PMN is $27.22 M
What is the all time high quarterly CFF for ProMIS Neurosciences?
ProMIS Neurosciences all-time high quarterly cash flow from financing activities is $27.22 M
What is ProMIS Neurosciences quarterly CFF year-on-year change?
Over the past year, PMN quarterly cash flow from financing activities has changed by +$8.96 M (+49.05%)
What is ProMIS Neurosciences TTM cash flow from financing activities?
The current TTM CFF of PMN is $26.90 M
What is the all time high TTM CFF for ProMIS Neurosciences?
ProMIS Neurosciences all-time high TTM cash flow from financing activities is $26.90 M
What is ProMIS Neurosciences TTM CFF year-on-year change?
Over the past year, PMN TTM cash flow from financing activities has changed by +$2.14 M (+8.65%)